1. Prediagnostic statin use was not associated with higher survival among patients with early breast cancer. 2. Postdiagnostic statin use...
1. The European Commission has authorized expanded venetoclax (Venclyxto) combinations for previously untreated chronic lymphocytic leukemia. 2. The approval reinforces...
1. Pfizer has committed $650 million upfront in a collaboration with Innovent Biologics that could ultimately reach $10.5 billion in...
1. Exposure to systemic glucocorticoid immunosuppression (gsISP) close to immune checkpoint inhibitor (ICI) initiation was associated with worse overall survival...
1. Upfront sentinel lymph node biopsy permitted the avoidance of axillary lymph node dissection in most patients with cN1 HR+/HER2-...
1. Sequential and upfront treatment of metastatic colorectal cancer (mCRC) with oxaliplatin (OX)-based therapy does not lead to significantly different...
1. Daraxonrasib significantly improves survival in metastatic pancreatic cancer compared with standard chemotherapy. 2. Strong response rates in combination therapy...
1. Incidence of early-onset metastatic adenocarcinoma increased among patients with multiple metastatic sites and those with peritoneum involvement. 2. Net...
1. The more invasive segment 4b/5 resection did not improve overall or disease-free survival compared to wedge resection in gallbladder...
1. Simvastatin (Zocor) in combination with paclitaxel (Taxol) is well tolerated and associated with significantly reduced disease progression compared to...
